PrimeRFP SCOUT · Federal Contract Recompete Brief

W91YTZ22P0056Chemistry analyzers and reagents — Ortho-Clinical Diagnostics Inc

Ortho-Clinical Diagnostics Inc holds $57.6M across 1,615 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. Competition previously drew 2 offers. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

W40m Rhco Atlantic
Awarding office
Ortho-Clinical Diagnostics Inc
Recipient
Sep 30, 2026
PoP end
$698K
Obligated
$1.4M
Potential
325413
NAICS
6640
PSC
NONE
Set-aside
2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ortho-Clinical Diagnostics Inc — $90

Contract facts

NONE
Contract numberW91YTZ22P0056
Also listed asW91YTZ-22-P-0056
AgencyW40m Rhco Atlantic
Awarding officeW40m Rhco Atlantic
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentOrtho-Clinical Diagnostics Inc
CAGE1C0L5
UEIJG5JF2JQJ121
NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6640
Place of performanceFORT LEE VA
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
Related solicitationW91YTZ22Q0049
PoP startMay 18, 2022
PoP end (current)Sep 30, 2026
Obligated$698K
Current value$813K
Potential value$1.4M

CHEMISTRY ANALYZERS AND REAGENTS is a federal NONE award for W40m Rhco Atlantic held by Ortho-Clinical Diagnostics Inc. Estimated value $1.4M ($698K obligated). Current period of performance ends Sep 30, 2026. Last award drew 2 bidders. Place of performance: FORT LEE VA. Related solicitation W91YTZ22Q0049.

Recompete timing

Public
Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Ortho-Clinical Diagnostics Inc$57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($57.6M) · all agencies
Department of Veterans Affairs (VA)$26.2M · 45%Department of Defense (DOD)$22.1M · 38%Department of Health and Human Services (HHS)$8.6M · 15%General Services Administration (GSA)$297K · 1%
Open full company profile

Related awards

Same incumbent
75H71024F80169
FY2024 LAB VITROS7600 REAGENTS/SUPPLIES TO BE ORDERED ON AN "AS NEEDED" BASIS, PART OF CPT…
$2.1M
Aug 31, 2026
FA466121F0075
VITROS CHEMICAL ANALYZER MAINTENANCE AND CALIBRATION
$336K
Aug 31, 2026
36C25925N0518
BLOOD BANK GEL ANALYZER COST PER TEST - SLC
$114K
Sep 6, 2026
36C25025N0968
BLOOD BANK ANALYZER, REAGENTS AND CONSUMABLES
$239K
Sep 14, 2026
FA489721F0042
CHEM ANALYZER SERVICES - EXERCISE OPTION YEAR 1
$717K
Sep 29, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract W91YTZ22P0056?

W91YTZ22P0056 (Chemistry analyzers and reagents) is a W40m Rhco Atlantic award with a potential value of $1.4M, currently held by Ortho-Clinical Diagnostics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W91YTZ-22-P-0056?

W91YTZ-22-P-0056 is the dashed form of PIID W91YTZ22P0056 (Chemistry analyzers and reagents), held by Ortho-Clinical Diagnostics Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W91YTZ22P0056?

W40m Rhco Atlantic awarded W91YTZ22P0056 to Ortho-Clinical Diagnostics Inc (potential $1.4M).

Who is the incumbent on W91YTZ22P0056?

Ortho-Clinical Diagnostics Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Ortho-Clinical Diagnostics Inc’s W91YTZ22P0056 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W91YTZ22P0056